drugset / Trial / NCT00402259

Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

NCT00402259

Phase 3 Completed 440 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of Esomeprazole and Omeprazole intravenous every 12 hours for 5 days in subjects with acute non-variceal upper gastrointestinal bleeding

Timeline

Start
2006-08
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule Intravenous
Subject Omeprazole Other / unclassified Intravenous

Indications

No indication recorded.